CCL5 and malignant colon neoplasm: In a mouse colon cancer model, the combination of OVT with a chemokine-enhancing cocktail that increased CCL5 and CXCL10 production while reducing CCL22 was demonstrated to boost the trafficking of T helper cells and CTLs to the TME and improve survival [77].